In addition to its serving as an enzyme, CD73 has been found to be over expressed in several types of human and mouse cancers such as breast (8), gastric (9), pancreatic (10), ovarian (11), melanoma (12) and bladder malignancy (13). This evidence concerns the gene NT5E and melanoma.